SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096211
Filing Date
2024-08-13
Accepted
2024-08-13 16:10:52
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grts-20240630.htm   iXBRL 10-Q 2480556
2 EX-10.1 grts-ex10_1.htm EX-10.1 65422
3 EX-31.1 grts-ex31_1.htm EX-31.1 18084
4 EX-31.2 grts-ex31_2.htm EX-31.2 18075
5 EX-32.1 grts-ex32_1.htm EX-32.1 15349
  Complete submission text file 0000950170-24-096211.txt   11460023

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT grts-20240630.xsd EX-101.SCH 1711072
82 EXTRACTED XBRL INSTANCE DOCUMENT grts-20240630_htm.xml XML 2156721
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 241201532
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)